Instant Quantification
of Genetic Modifications AAV Titer Edits AAV Structural Variants Knock-in Off-targets Single-bp Edits Genome Integrity Large Deletions
for Cell and Gene Therapies
Accelerate your R&D, IND, and Process Development programs with QUiCKR Kits.
Explore cost and time savings for your program
Explore cost and time savings for your program
Based on 3,936 samples processed per program
Time & Cost Impact
Processing time saved
48.2days / program
Total cost saved
$212.5K/ program
Business Impact (Estimated)
Runway saved
$1.85M/ program
Future sales captured
$18.53M/ program
Amp-Seq (NGS) run time440 hr (55.0 days)
QUiCKR run time55 hr (6.8 days)
Run time saved48.2 days
Total phase duration11 weeks
Total program duration with Amp-Seq (NGS)22.0 weeks
Total program duration with QUiCKR12.4 weeks
Hands-on hours saved76 hrs
10,000+ samples analyzed to date
QUiCKR Technology
Example Results
Meet Our Team
We are passionate about accelerating broad access to life saving genetic medicines. Our mission is to engineer tools that test genetic modifications instantaneously. Imagine a world where genetic engineering can iterate as fast as software engineering.
Leadership
Charles Blanluet
CEO & Cofounder
Stanford Microfludics, Guardant
Prof. Juan Santiago
Scientific Cofounder
Stanford Microfludics, Purigen Biosystems
Jiawei Lee
CBO & Cofounder
UC Berkeley & UCSF, Sequoia
Henrik Sperber
CTO & Cofounder
CRISPR Therapeutics, Paratus Sciences
Kristian Laursen
CSO
Weill Cornell Medicine, Paratus Sciences
Advisors
Prof. Matthew Porteus
Scientific Advisor
Stanford Medicine, CRISPR Therapeutics
Hari Jayaram
Scientific Advisor
Verve Therapeutics, Editas Medicine, Arena BioWorks
Sepehr Kiani
Business Advisor
Fluent Biosciences, Bio-Rad
Paul Donohoue